{
  "Label": "GEP-Extract",
  "Mode": "Calculation",
  "StaticValues": false,
  "CreatedDate": "2022-06-21T15:09:25.5059142+00:00",
  "SimulationId": "c6644c26-be7b-4454-995b-59b6e6cde2b8_72",
  "ModelId": "8744a6e0-8f1f-4277-890f-9536b1761fb3",
  "ModelType": "Portfolio",
  "ModelName": "Governance Endorsed Portfolio",
  "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/portfolio/8744a6e0-8f1f-4277-890f-9536b1761fb3/composition",
  "ParentId": null,
  "ParentName": null,
  "Properties": {},
  "ChildSimulations": [
    {
      "SimulationId": "f50fcc29-b4f0-ec11-b47a-0003ffebd6d2_4",
      "ModelId": "70ba91b0-6507-495e-91a8-a27ef93e9c3c",
      "ModelType": "ProgramOption",
      "ModelName": "GEP",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/896866ba-8dde-4e49-80d0-eccb7feb0a90/70ba91b0-6507-495e-91a8-a27ef93e9c3c/input",
      "ParentId": "896866ba-8dde-4e49-80d0-eccb7feb0a90",
      "ParentName": "ARV-471 1L HR+/HER2- mBC",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C489b",
        "Candidate Type": "PE",
        "Compound Number": "PF-07850327",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Aadith Penmetsa",
        "Project Name": "ARV-471 1L HR+/HER2- mBC",
        "Project Reporting Name": "ARV-471 1L HR+/HER2- mBC"
      }
    },
    {
      "SimulationId": "35fd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "205d5a6d-c391-4eb4-835a-8a2c0181752f",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/a14192f1-2e2a-48d2-bc51-60e0521ad4b5/205d5a6d-c391-4eb4-835a-8a2c0181752f/input",
      "ParentId": "a14192f1-2e2a-48d2-bc51-60e0521ad4b5",
      "ParentName": "Braftovi / Mektovi BRAF+ Melanoma triplet",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C422d",
        "Candidate Type": "PE",
        "Compound Number": "PF-07263896",
        "Compound Type": "PE",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Braftovi / Mektovi BRAF+ Melanoma triplet",
        "Project Reporting Name": "Braftovi / Mektovi BRAF+ Melanoma triplet"
      }
    },
    {
      "SimulationId": "0d700f93-84d7-ec11-b656-0003ffeb75b3_49",
      "ModelId": "4fc10228-cc8d-41c9-9afe-872db6a733a2",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/c360ee71-18a2-40e9-9ce3-8ebba6811b2f/4fc10228-cc8d-41c9-9afe-872db6a733a2/input",
      "ParentId": "c360ee71-18a2-40e9-9ce3-8ebba6811b2f",
      "ParentName": "Eucrisa Flare Prevention",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C329a_1",
        "Candidate Type": "PE",
        "Compound Number": "PF-06930164",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Eucrisa Flare Prevention",
        "Project Reporting Name": "Eucrisa Flare Prevention"
      }
    },
    {
      "SimulationId": "7d8290ff-e3e0-ec11-b656-0003ffeb75b3_30",
      "ModelId": "9f3a1f54-385a-43b6-b8ca-6e4521429393",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/5a563107-17f0-4a59-a5bf-ef5a8870e2a6/9f3a1f54-385a-43b6-b8ca-6e4521429393/input",
      "ParentId": "5a563107-17f0-4a59-a5bf-ef5a8870e2a6",
      "ParentName": "PF-06425090 C. diff vax",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "B509a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06425090",
        "Compound Type": "Prophylactic Vaccine ",
        "PDA Representative": "Michael Rodriguez ",
        "Project Name": "PF-06425090 C. diff vax",
        "Project Reporting Name": "C. difficile vaccine"
      }
    },
    {
      "SimulationId": "4d6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "593a244f-2ca6-4ba2-9b2f-5fb89fbf175c",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/348e6844-f5a9-4a84-84bc-8fd2aaddcf1c/593a244f-2ca6-4ba2-9b2f-5fb89fbf175c/input",
      "ParentId": "348e6844-f5a9-4a84-84bc-8fd2aaddcf1c",
      "ParentName": "Orgovyx - Endometriosis",
      "Properties": {
        "Business Category": "IM",
        "Candidate Code": "C475c",
        "Candidate Type": "PE",
        "Compound Number": "PF-07822005",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Dave Culhane",
        "Project Name": "Orgovyx - Endometriosis",
        "Project Reporting Name": "Orgovyx - Endometriosis"
      }
    },
    {
      "SimulationId": "526dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "d4f3a3bc-a4d9-40db-90c7-61c25a9fe1c6",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/8fc06ded-f962-4c16-a0b8-cd0f37ce3896/d4f3a3bc-a4d9-40db-90c7-61c25a9fe1c6/input",
      "ParentId": "8fc06ded-f962-4c16-a0b8-cd0f37ce3896",
      "ParentName": "PF-04965842 JAK1 Atopic Dermatitis",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "B745d",
        "Candidate Type": "NME",
        "Compound Number": "PF-04965842",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Abrocitinib (JAK1) AD",
        "Project Reporting Name": "PF-04965842 JAK1 Atopic Dermatitis"
      }
    },
    {
      "SimulationId": "5c6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "da29e897-d6a5-4a98-be63-7eb05863e7b1",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/8d244697-3c00-4ffa-b660-7effb154a3c5/da29e897-d6a5-4a98-be63-7eb05863e7b1/input",
      "ParentId": "8d244697-3c00-4ffa-b660-7effb154a3c5",
      "ParentName": "PF-06651600 JAK3 Alopecia",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "B798d",
        "Candidate Type": "NME",
        "Compound Number": "PF-06651600",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "PF-06651600 JAK3 Alopecia",
        "Project Reporting Name": "Ritlecitinib (JAK3/TEC) Alopecia"
      }
    },
    {
      "SimulationId": "616dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "2f89e664-3314-4b13-93dc-129ade6142f5",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/bf76695e-2396-46ab-a3a0-7372eaef8b43/2f89e664-3314-4b13-93dc-129ade6142f5/input",
      "ParentId": "bf76695e-2396-46ab-a3a0-7372eaef8b43",
      "ParentName": "PF-06741086 TFPI hemo",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "B784a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06741086",
        "Compound Type": "Antibody or Antibody Fragment",
        "PDA Representative": "Diane Thara",
        "Project Name": "PF-06741086 TFPI hemo",
        "Project Reporting Name": "Marstacimab (aTFPI) Hemophilia"
      }
    },
    {
      "SimulationId": "666dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "2f3b183a-d8e1-4bd6-ad27-b222ab381499",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/a93498bc-22ce-4caa-a911-24c575ea61c5/2f3b183a-d8e1-4bd6-ad27-b222ab381499/input",
      "ParentId": "a93498bc-22ce-4caa-a911-24c575ea61c5",
      "ParentName": "PF-06802861 LMNA-related DCM",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "C441a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07265803",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Diane Thara",
        "Project Name": "LMNA Cardiomyopathy",
        "Project Reporting Name": "LMNA Cardiomyopathy"
      }
    },
    {
      "SimulationId": "6b6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "b90328e1-fdae-494c-b0bc-0981f835f1b8",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/de06e0c6-3502-4ca0-adf9-47e7aa8f14e7/b90328e1-fdae-494c-b0bc-0981f835f1b8/input",
      "ParentId": "de06e0c6-3502-4ca0-adf9-47e7aa8f14e7",
      "ParentName": "PF-06882961 Oral GLP-1 Agonist for Obesity",
      "Properties": {
        "Business Category": "IM",
        "Candidate Code": "C342c",
        "Candidate Type": "PE",
        "Compound Number": "PF-06882961",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Dave Culhane",
        "Project Name": "Danuglipron Obesity",
        "Project Reporting Name": "Danuglipron Obesity"
      }
    },
    {
      "SimulationId": "706dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "de03b2b6-4e3a-49e1-8945-f4a2e9c009ec",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/1229c619-0dc3-44e9-b5d3-4782e9116b83/de03b2b6-4e3a-49e1-8945-f4a2e9c009ec/input",
      "ParentId": "1229c619-0dc3-44e9-b5d3-4782e9116b83",
      "ParentName": "PF-07612577 - Avibactam Prodrug w/ Ceftibuten Dihydrate",
      "Properties": {
        "Business Category": "Hospital",
        "Candidate Code": "C469a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07612577",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Robert Abramov",
        "Project Name": "Avibactam Prodrug w/ Ceftibuten Dihydrate",
        "Project Reporting Name": "Avibactam Prodrug w/ Ceftibuten Dihydrate"
      }
    },
    {
      "SimulationId": "166dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "3bfd4ab8-a939-4de4-b306-ba6aef76c22a",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/d1080ec2-a886-4256-ae00-a53c060c4e8c/3bfd4ab8-a939-4de4-b306-ba6aef76c22a/input",
      "ParentId": "d1080ec2-a886-4256-ae00-a53c060c4e8c",
      "ParentName": "Elranatamab BCMA-BS MM Triple R/R",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C107a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06863135",
        "Compound Type": "Novel Protein Scaffold",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Elranatamab BCMA-BS MM Triple R/R",
        "Project Reporting Name": "Elranatamab MM Triple R/R"
      }
    },
    {
      "SimulationId": "796dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "b8468148-b937-49c1-82e7-8c7ac8690507",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/3ebcf0e9-5be4-46da-be17-722181bce12a/b8468148-b937-49c1-82e7-8c7ac8690507/input",
      "ParentId": "3ebcf0e9-5be4-46da-be17-722181bce12a",
      "ParentName": "Pneumococal Next Generation Vaccine - Infant",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "B747c",
        "Candidate Type": "NME",
        "Compound Number": "PF-06482077",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": "PCV20 Infant",
        "Project Reporting Name": "PCV20 Infant"
      }
    },
    {
      "SimulationId": "7f6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "c5ee07a4-638f-437e-8632-3fef6a1fe9d7",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/1676b414-1bc8-430e-b1cd-192360fc0653/c5ee07a4-638f-437e-8632-3fef6a1fe9d7/input",
      "ParentId": "1676b414-1bc8-430e-b1cd-192360fc0653",
      "ParentName": "Pneumococal Next Generation Vaccine - Infant - Multi Dose Vial",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "B747c_1",
        "Candidate Type": "PE",
        "Compound Number": "PF-06482077",
        "Compound Type": "N/A",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": "Pneumococal Next Generation Vaccine - Infant - Multi Dose Vial",
        "Project Reporting Name": "PCV20 Infant - Multi Dose Vial"
      }
    },
    {
      "SimulationId": "8e6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "5f84c3e3-6ce6-4992-8467-b4cc2a2258dc",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/8b052b8c-7b6f-4caa-bef7-54dde7ec5536/5f84c3e3-6ce6-4992-8467-b4cc2a2258dc/input",
      "ParentId": "8b052b8c-7b6f-4caa-bef7-54dde7ec5536",
      "ParentName": "RSV Maternal",
      "Properties": {
        "Business Category": "Hospital",
        "Candidate Code": "C367b",
        "Candidate Type": "PE",
        "Compound Number": "PF-06928316",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": "RSV Maternal Vaccine",
        "Project Reporting Name": "RSV Maternal Vaccine"
      }
    },
    {
      "SimulationId": "936dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "040d716f-1dd7-4db2-befb-8c01be379db0",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/0fe38b73-d257-432c-8981-8e256318982f/040d716f-1dd7-4db2-befb-8c01be379db0/input",
      "ParentId": "0fe38b73-d257-432c-8981-8e256318982f",
      "ParentName": "RSV Older Adult",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "C367a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06928316",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": "RSV Older Adult",
        "Project Reporting Name": "RSV Older Adult"
      }
    },
    {
      "SimulationId": "9c6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "a5f23abd-4725-493f-97fd-bd82a1ea3b79",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/ba14cac9-3b75-4723-a149-facd8f768b68/a5f23abd-4725-493f-97fd-bd82a1ea3b79/input",
      "ParentId": "ba14cac9-3b75-4723-a149-facd8f768b68",
      "ParentName": "Somatrogon (MOD-4023) - Peds GHD",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "C031b",
        "Candidate Type": "NME",
        "Compound Number": "PF-06836922",
        "Compound Type": "Other Protein Therapeutic",
        "PDA Representative": "Diane Thara",
        "Project Name": "Somatrogon (MOD-4023) - Peds GHD",
        "Project Reporting Name": "Somatrogon GHD Peds"
      }
    },
    {
      "SimulationId": "256dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "e3c3d091-edda-4203-b312-1e6932de4b51",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/edb04d60-a52b-4d91-ac74-ff1b675c452f/e3c3d091-edda-4203-b312-1e6932de4b51/input",
      "ParentId": "edb04d60-a52b-4d91-ac74-ff1b675c452f",
      "ParentName": "Etrasimod Crohns Disease",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C504b",
        "Candidate Type": "PE",
        "Compound Number": "PF-07915503",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Etrasimod Crohns Disease",
        "Project Reporting Name": "Etrasimod Crohn's"
      }
    },
    {
      "SimulationId": "2de2f3a0-d3d6-ec11-b656-0003ffeb75b3_49",
      "ModelId": "3317c023-5282-40ac-9061-9b0afc53878f",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/86d71b4e-8799-4d19-948f-432a1729f41a/3317c023-5282-40ac-9061-9b0afc53878f/input",
      "ParentId": "86d71b4e-8799-4d19-948f-432a1729f41a",
      "ParentName": "ROBO2-FSGS (LPD)",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "C022a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06730512",
        "Compound Type": "Native or Fusion Protein",
        "PDA Representative": "Diane Thara",
        "Project Name": "ROBO2-FSGS",
        "Project Reporting Name": "ROBO2 Nephrotic Syndrome"
      }
    },
    {
      "SimulationId": "4efd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "1a6ffc7a-4c7c-4565-86bc-b3ddf33e2b4e",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/4f5963a7-49ad-4c9c-a18d-54c5fa148b1e/1a6ffc7a-4c7c-4565-86bc-b3ddf33e2b4e/input",
      "ParentId": "4f5963a7-49ad-4c9c-a18d-54c5fa148b1e",
      "ParentName": "TTI-622 1L High Risk DLBCL",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C497d",
        "Candidate Type": null,
        "Compound Number": null,
        "Compound Type": "Small Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "TTI-622 1L High Risk DLBCL",
        "Project Reporting Name": "TTI-622 1L High Risk DLBCL"
      }
    },
    {
      "SimulationId": "53fd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "58609a3a-d97a-4d70-ae7e-fa7e8e88dfd7",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/afeb316e-192d-4a4d-96cd-efe224aea027/58609a3a-d97a-4d70-ae7e-fa7e8e88dfd7/input",
      "ParentId": "afeb316e-192d-4a4d-96cd-efe224aea027",
      "ParentName": "TTI-622 2L+DCR MM",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C497b",
        "Candidate Type": null,
        "Compound Number": null,
        "Compound Type": "Small Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "TTI-622 2L+DCR MM",
        "Project Reporting Name": "TTI-622 2L+DCR MM"
      }
    },
    {
      "SimulationId": "57fd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "e09f1caa-2474-4682-aa00-1ace2746b996",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/2b63fcd3-d16e-404d-aace-582130dc50a8/e09f1caa-2474-4682-aa00-1ace2746b996/input",
      "ParentId": "2b63fcd3-d16e-404d-aace-582130dc50a8",
      "ParentName": "TTI-622 2L+SCT Inel DLBCL",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C497c",
        "Candidate Type": null,
        "Compound Number": null,
        "Compound Type": "Small Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "TTI-622 2L+SCT Inel DLBCL",
        "Project Reporting Name": "TTI-622 2L+SCT Inel DLBCL"
      }
    },
    {
      "SimulationId": "5dfd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "ff86c0e7-288f-4ab9-b6d0-f18316769b41",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/ab320f62-2251-4468-84f2-9de4ef42a0ba/ff86c0e7-288f-4ab9-b6d0-f18316769b41/input",
      "ParentId": "ab320f62-2251-4468-84f2-9de4ef42a0ba",
      "ParentName": "TTI-622 3L+TCR MM",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C497a",
        "Candidate Type": null,
        "Compound Number": null,
        "Compound Type": "Small Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "TTI-622 3L+TCR MM",
        "Project Reporting Name": "TTI-622 3L+TCR MM"
      }
    },
    {
      "SimulationId": "62fd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "bc1d945b-471a-46e0-a587-140911bd4c25",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/b9768c78-c9be-4e20-9b3b-b14fd322fcbc/bc1d945b-471a-46e0-a587-140911bd4c25/input",
      "ParentId": "b9768c78-c9be-4e20-9b3b-b14fd322fcbc",
      "ParentName": "VLA15 Lyme Vaccine",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "C460a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07307405",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": " VLA15 Lyme Vaccine",
        "Project Reporting Name": "Valneva Lyme Vaccine "
      }
    },
    {
      "SimulationId": "67fd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "41c7e6a8-f8bf-450d-b970-78fe042e3534",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/69c9390f-3cae-475c-9a64-5b76a8ec7f51/41c7e6a8-f8bf-450d-b970-78fe042e3534/input",
      "ParentId": "69c9390f-3cae-475c-9a64-5b76a8ec7f51",
      "ParentName": "VLA15 Lyme Vaccine (LPD)",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "C460a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07307405",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez",
        "Project Name": "VLA15 Lyme Vaccine",
        "Project Reporting Name": "Valneva Lyme Vaccine "
      }
    },
    {
      "SimulationId": "6cfd1dd2-04cb-ec11-997e-0003ffebe488_69",
      "ModelId": "98f7d5a7-477d-40c2-bdf8-0dad167abeb0",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/9a67abb9-8404-404b-937a-6ddbe573572a/98f7d5a7-477d-40c2-bdf8-0dad167abeb0/input",
      "ParentId": "9a67abb9-8404-404b-937a-6ddbe573572a",
      "ParentName": "Xtandi nmHSPC (EMBARK)",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C343d",
        "Candidate Type": "PE",
        "Compound Number": "PF-04998299",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Xtandi nmHSPC (EMBARK)",
        "Project Reporting Name": "Xtandi nmHSPC (EMBARK)"
      }
    },
    {
      "SimulationId": "f86cc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "35d9f1d9-ef71-4fb9-bf07-fda6eb114631",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/4a4af10b-be72-462c-b2c2-e344da1e4cd8/35d9f1d9-ef71-4fb9-bf07-fda6eb114631/input",
      "ParentId": "4a4af10b-be72-462c-b2c2-e344da1e4cd8",
      "ParentName": "CDK2+palbo+ET (LPD)",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C416b",
        "Candidate Type": "NME",
        "Compound Number": null,
        "Compound Type": "Small Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "CDK2+palbo+ET",
        "Project Reporting Name": "CDK2+palbo+ET"
      }
    },
    {
      "SimulationId": "026dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "73768b99-6dfb-41d9-a18f-7eb420d972fa",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/3d807e84-ab3d-47ef-8d66-f5061ff61635/73768b99-6dfb-41d9-a18f-7eb420d972fa/input",
      "ParentId": "3d807e84-ab3d-47ef-8d66-f5061ff61635",
      "ParentName": "Elranatamab BCMA-BS MM Double R/R",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C107c",
        "Candidate Type": "PE",
        "Compound Number": "PF-06863135",
        "Compound Type": "Novel Protein Scaffold",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Elranatamab BCMA-BS MM Double R/R",
        "Project Reporting Name": "Elranatamab BCMA-BS MM Double R/R"
      }
    },
    {
      "SimulationId": "076dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "1ce4f877-abee-4a68-8202-1f9622dbbf78",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/8d9be667-d238-4501-a0d4-c433434145cc/1ce4f877-abee-4a68-8202-1f9622dbbf78/input",
      "ParentId": "8d9be667-d238-4501-a0d4-c433434145cc",
      "ParentName": "Elranatamab BCMA-BS MM MRD+",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C107i",
        "Candidate Type": "PE",
        "Compound Number": "PF-06863135",
        "Compound Type": "Novel Protein Scaffold",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Elranatamab BCMA-BS MM MRD+",
        "Project Reporting Name": "Elranatamab BCMA-BS MM Newly-diagnosed TE"
      }
    },
    {
      "SimulationId": "0c6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "e4a0aea7-475b-4459-9148-de2478e19c5c",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/9eceb3af-f554-4323-9202-484e67ce1877/e4a0aea7-475b-4459-9148-de2478e19c5c/input",
      "ParentId": "9eceb3af-f554-4323-9202-484e67ce1877",
      "ParentName": "Elranatamab BCMA-BS MM Newly-Diagnosed",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C107d",
        "Candidate Type": "PE",
        "Compound Number": "PF-06863135",
        "Compound Type": "Novel Protien Scaffold",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Elranatamab BCMA-BS MM Newly-Diagnosed",
        "Project Reporting Name": "Elranatamab BCMA-BS MM Newly-diagnosed TI"
      }
    },
    {
      "SimulationId": "116dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "6da3a40a-f2a2-4008-bc42-c81291f4aa94",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/2a450298-c4fc-41bc-863b-f6f2e852b718/6da3a40a-f2a2-4008-bc42-c81291f4aa94/input",
      "ParentId": "2a450298-c4fc-41bc-863b-f6f2e852b718",
      "ParentName": "Elranatamab BCMA-BS MM Newly-diagnosed (GEP)",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "C107d",
        "Candidate Type": "PE",
        "Compound Number": "PF-06863135",
        "Compound Type": "Novel Protein Scaffold",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Elranatamab BCMA-BS MM Newly-diagnosed (GEP)",
        "Project Reporting Name": "Elranatamab BCMA-BS MM Newly-diagnosed TI"
      }
    },
    {
      "SimulationId": "1a6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "a5adbd70-a8ab-4684-8737-46ab1c55c717",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/f4fa9cfc-7f53-454a-8510-b522fb14338e/a5adbd70-a8ab-4684-8737-46ab1c55c717/input",
      "ParentId": "f4fa9cfc-7f53-454a-8510-b522fb14338e",
      "ParentName": "Etrasimod Alopecia Areata",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C504e",
        "Candidate Type": "PE",
        "Compound Number": "PF-07915503",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Etrasimod Alopecia Areata",
        "Project Reporting Name": "Etrasimod Alopecia Areata"
      }
    },
    {
      "SimulationId": "206dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "89d705a5-c8a2-4864-a157-bf7756f82793",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/acce24bc-e673-4ac9-9c64-d6a74d56fc2c/89d705a5-c8a2-4864-a157-bf7756f82793/input",
      "ParentId": "acce24bc-e673-4ac9-9c64-d6a74d56fc2c",
      "ParentName": "Etrasimod Atopic Dermatitis",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C504c",
        "Candidate Type": "PE",
        "Compound Number": "PF-07915503",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Etrasimod Atopic Dermatitis",
        "Project Reporting Name": "Antioch AD"
      }
    },
    {
      "SimulationId": "2a6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "aeb9a796-ab2f-4e0c-b840-8190b101146c",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/aa5cfe5a-8f54-466a-8987-341dc01271e5/aeb9a796-ab2f-4e0c-b840-8190b101146c/input",
      "ParentId": "aa5cfe5a-8f54-466a-8987-341dc01271e5",
      "ParentName": "Etrasimod Eosinophilic Esophagitis",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C504d",
        "Candidate Type": "PE",
        "Compound Number": "PF-07915503",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Etrasimod Eosinophilic Esophagitis",
        "Project Reporting Name": "Etrasimod EoE"
      }
    },
    {
      "SimulationId": "2f6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "cf514421-add1-4030-8d08-e91c1eeaf47f",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/d00da901-6428-4d63-bf93-4540e04c25d6/cf514421-add1-4030-8d08-e91c1eeaf47f/input",
      "ParentId": "d00da901-6428-4d63-bf93-4540e04c25d6",
      "ParentName": "Etrasimod Ulcerative Colitis",
      "Properties": {
        "Business Category": "I&I",
        "Candidate Code": "C504a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07915503",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Jim Albright",
        "Project Name": "Etrasimod Ulcerative Colitis",
        "Project Reporting Name": "Etrasimod UC"
      }
    },
    {
      "SimulationId": "396dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "67ed2dc4-1547-4ac2-bf5e-e4b0c95f1c70",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/aca96a8f-7c19-444f-96ee-f2fd934c280b/67ed2dc4-1547-4ac2-bf5e-e4b0c95f1c70/input",
      "ParentId": "aca96a8f-7c19-444f-96ee-f2fd934c280b",
      "ParentName": "Hem B FIX GTx (SPK)",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "C037a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06838435",
        "Compound Type": "Gene Therapy",
        "PDA Representative": "Diane Thara",
        "Project Name": "Hem B FIX GTx (SPK)",
        "Project Reporting Name": "FidaVec HemB GTx"
      }
    },
    {
      "SimulationId": "3e6dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "5d0432f5-7b0b-49d9-8ae2-d22f0fff7be9",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/00c9dbf6-aa75-4455-98fc-0a6bb612192d/5d0432f5-7b0b-49d9-8ae2-d22f0fff7be9/input",
      "ParentId": "00c9dbf6-aa75-4455-98fc-0a6bb612192d",
      "ParentName": "HemA GTx",
      "Properties": {
        "Business Category": "Rare Disease",
        "Candidate Code": "C373a",
        "Candidate Type": "NME",
        "Compound Number": "PF-07055480",
        "Compound Type": "Gene Therapy",
        "PDA Representative": "Diane Thara",
        "Project Name": "HemA GTx",
        "Project Reporting Name": "GiroctoVec HemA GTx"
      }
    },
    {
      "SimulationId": "436dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "46456f41-23d7-4a68-8ed2-1d7da959f751",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/a5076ea9-e865-4eda-8476-1c0508e5da52/46456f41-23d7-4a68-8ed2-1d7da959f751/input",
      "ParentId": "a5076ea9-e865-4eda-8476-1c0508e5da52",
      "ParentName": "Ibrance Her2+ ABC",
      "Properties": {
        "Business Category": "Oncology",
        "Candidate Code": "A548i",
        "Candidate Type": "PE",
        "Compound Number": "PD-332991",
        "Compound Type": "Small Organic Molecule",
        "PDA Representative": "Peter Hogue",
        "Project Name": "Ibrance HER2+ ABC",
        "Project Reporting Name": "Ibrance HER2+ ABC"
      }
    },
    {
      "SimulationId": "486dc9a9-94d0-ec11-b656-0003ffeb75b3_62",
      "ModelId": "9425dab8-dd89-4e17-b4ee-d0cc7fa9ed99",
      "ModelType": "ProgramOption",
      "ModelName": "Default",
      "ModelURL": "/initiative/d30dd05c-f143-430d-9c71-0e978f333ff9/project/0f0255da-5da4-4f2a-a6d7-5de029d34f1f/9425dab8-dd89-4e17-b4ee-d0cc7fa9ed99/input",
      "ParentId": "0f0255da-5da4-4f2a-a6d7-5de029d34f1f",
      "ParentName": "Mn ACWYB vaccine (Penta Adolescent US)",
      "Properties": {
        "Business Category": "Vaccines",
        "Candidate Code": "C351a",
        "Candidate Type": "NME",
        "Compound Number": "PF-06886992",
        "Compound Type": "Prophylactic Vaccine",
        "PDA Representative": "Michael Rodriguez ",
        "Project Name": "Mn ACWYB vaccine (Penta Adolescent US)",
        "Project Reporting Name": "Meningococcal Pentavalent Vaccine"
      }
    }
  ]
}